Treatment of Diabetic Foot Ulcers With AUP1602-C

Summary

This is a two-part phase 1/2A study performed in diabetic foot ulcer (DFU) patients with chronic non-healing wounds to investigate the safety and efficacy of AUP1602-C.

Timeline

Start

2020-01-28

Primary completion

2023-03-20

Completion

2023-03-20

Publications

• Schindler C, Mikosinski J, Mikosinski P, Karkkainen HR, Sanio M, Kurkipuro J, Mierau I, Smith W, Vartiainen A, Decory L, Weber D, Wirth T, Yrjanheikki J, Schellong S, Samaranayake H. Multi-target gene therapy AUP1602-C to improve healing and quality of life for diabetic foot ulcer patients: a phase I, open-label, dose-finding study. Ther Adv Endocrinol Metab. 2024 Nov 4;15:20420188241294134. doi: 10.1177/20420188241294134. eCollection 2024.

Drugs

Indications